BIOCON Extends Winning Streak Despite Large Block Deal Overhang

shares gained more than 6% on 14 July 2026, marking their fourth consecutive session of gains and touching the highest level since 25 May 2026. The stock remained in focus after reports indicated that Viatris-owned Mylan is seeking to exit its stake in the company through a proposed block deal valued at approximately ₹3,481 crore. According to reports, the floor price for the transaction has been set at ₹378.50 per share, representing a discount of around 7.9% to Biocon’s previous closing price on 13 July. Despite the sizeable stake sale proposal, investor participation remained strong, keeping the stock among the key market movers during the session. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.